Year-end Sale % OFF 
Abstract
The aim of the present study was to evaluate the effects of two treatments for masseteric hypertrophy. In total, 24 patients with masseteric hypertrophy were enrolled in this study. Patients were randomly divided into two groups: 12 individuals were treated with radiofrequency (RF) ablation and 12 patients received an injection of botulinum toxin A. The thickness of the masseter muscle under tension was measured using ultrasound and clinical photographs were captured prior to treatment and at 6 and 12 months following treatment. Complications were observed during 12-month follow-up. In the group injected with botulinum toxin A, masseteric muscle thickness decreased to the lowest point 6 months after the injections but increased until 12 months after injection. However, in the group treated with RF ablation, muscle thickness decreased steadily over the 12 months following surgery. Therefore, the results of the present study indicated that the effect of RF ablation on the thickness of the masseter muscle may be much larger than that obtained following injection with botulinum toxin A.
Highlights
Benign masseteric hypertrophy is a major reason for a wide lower face
Several treatment methods may be used on patients with masseteric hypertrophy in order to improve facial contours
Park et al reported on radiofrequency (RF) volumetric reduction for masseteric hypertrophy [3]
Summary
Several treatment methods may be used on patients with masseteric hypertrophy in order to improve facial contours. The major treatment methods involve surgery, including mandibular angle osteotomy and masseter muscle resection, and there are non‐surgical methods, including injection with botulinum toxin type A [1,2]. RF‐induced tissue coagulation necrosis of the masseter muscle did not lead to any infections or limitations with regard to mouth opening, and the clinical improvement was well maintained following treatment [3]. Far, there have been no studies on the efficacy and safety of RF and injection with botulinum toxin A for the treatment of masseteric hypertrophy. These two methods were compared by measuring the thickness of the masseter muscle at 6 and 12 months following surgery
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
